bayh-dole

Top legal experts: Laws protecting IP aren’t tools for drug price controls

Legislation to encourage innovation and protect patent holders should not be distorted into
Read More
Lab

Poll: U.S. voters support the Bayh-Dole Act, but fear its misuse by lawmakers

At least three-quarters of U.S. voters favor keeping the Bayh-Dole Act to back
Read More
fda-approval-drug-research-development

Amicus Therapeutics wins FDA approval for breakthrough late-onset Pompe therapy

The U.S. Food and Drug Administration (FDA) has approved a therapy used for
Read More
rice farming

Climate change is threatening rice farming—can crops be kept afloat?

Climate change is wreaking havoc across the globe, notably endangering agriculture. Crops and
Read More
18-FDA

BIO surveying biotech firms on how to improve communications with the FDA

The Biotechnology Innovation Organization (BIO) is surveying biotech companies about their interactions with
Read More
sepsis awareness

Battling sepsis and superbugs requires awareness and policy

Generated by our own internal defenses, sepsis claims 350,000 adult lives each year
Read More

EDITORS' CHOICE

biotech sisterhood

Meet the biotech sisterhood—women supporting women in the pharma sector

“The biotech sisterhood is the antidote to the pharma bros,” said Angie You, Ph.D., Chief Executive Officer at Architect Therapeutics, during a lively conversation with
Read More

LATEST NEWS

Diversity, Equity, Inclusion

This Hispanic Heritage Month comes with opportunities, challenges, and a chance to reflect

Hispanic Heritage Month, from September 15 to October 15, serves as an important opportunity to remember and honor the contributions of the Hispanic community to
Federal Policy

Top legal experts: Laws protecting IP aren’t tools for drug price controls

Legislation to encourage innovation and protect patent holders should not be distorted into instruments for drug price controls, a high-profile group of former judges, federal
Bioeconomy

Poll: U.S. voters support the Bayh-Dole Act, but fear its misuse by lawmakers

At least three-quarters of U.S. voters favor keeping the Bayh-Dole Act to back innovation and research, but are concerned that it may be “misused for
Health

Amicus Therapeutics wins FDA approval for breakthrough late-onset Pompe therapy

The U.S. Food and Drug Administration (FDA) has approved a therapy used for the treatment of late-onset Pompe disease (LOPD). The two-component therapy is manufactured
Agriculture

Climate change is threatening rice farming—can crops be kept afloat?

Climate change is wreaking havoc across the globe, notably endangering agriculture. Crops and animals are equally affected, as rising temperatures raise concerns among farmers. One

BIO to Congress: IRA's price controls harm R&D

Drug price controls in the Inflation Reduction Act (IRA) harm drug R&D, John Crowley, CEO of Amicus Therapeutics and BIO Board Vice Chair, testified on September 21.

AGRICULTURE

Climate Change

rice farming

Climate change is threatening rice farming—can crops be kept afloat?

Climate change is wreaking havoc across the globe, notably endangering agriculture. Crops and animals are equally affected, as rising temperatures
Read More

Federal Policy

State Policy

International

Bio's View

GET DAILY BIOTECH NEWS IN YOUR INBOX

Scroll to Top
SUBSCRIBE TO THE FREE GOOD DAY BIO NEWSLETTER